A detailed history of Virginia Retirement Systems Et Al transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 14,000 shares of IRWD stock, worth $46,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,000
Holding current value
$46,900
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

BUY
$8.25 - $11.35 $115,500 - $158,900
14,000 New
14,000 $134,000
Q1 2023

Jul 11, 2023

BUY
$10.37 - $12.56 $13,480 - $16,328
1,300 Added 7.69%
18,200 $191,000
Q4 2022

May 17, 2023

BUY
$9.9 - $12.43 $167,310 - $210,067
16,900 New
16,900 $209 Million
Q3 2022

May 16, 2023

SELL
$10.14 - $12.38 $1.07 Million - $1.3 Million
-105,400 Closed
0 $0
Q1 2022

Apr 21, 2022

SELL
$10.61 - $12.88 $464,718 - $564,144
-43,800 Reduced 29.36%
105,400 $1.33 Million
Q4 2021

Feb 03, 2022

SELL
$10.86 - $13.95 $630,966 - $810,495
-58,100 Reduced 28.03%
149,200 $1.74 Million
Q3 2021

Oct 21, 2021

SELL
$11.92 - $13.92 $233,632 - $272,832
-19,600 Reduced 8.64%
207,300 $2.71 Million
Q2 2021

Aug 13, 2021

BUY
$10.16 - $13.11 $42,672 - $55,062
4,200 Added 1.89%
226,900 $2.92 Million
Q1 2021

Apr 30, 2021

BUY
$9.04 - $11.86 $825,351 - $1.08 Million
91,300 Added 69.48%
222,700 $2.49 Million
Q4 2020

Feb 16, 2021

BUY
$9.05 - $12.2 $253,400 - $341,600
28,000 Added 27.08%
131,400 $1.5 Million
Q3 2020

Nov 12, 2020

BUY
$8.99 - $10.74 $619,411 - $739,986
68,900 Added 199.71%
103,400 $930,000
Q2 2020

Aug 12, 2020

SELL
$9.14 - $11.97 $7,312 - $9,576
-800 Reduced 2.27%
34,500 $356,000
Q1 2020

May 12, 2020

BUY
$8.58 - $14.01 $137,280 - $224,160
16,000 Added 82.9%
35,300 $356,000
Q4 2019

Jan 27, 2020

BUY
$8.22 - $14.0 $158,646 - $270,200
19,300 New
19,300 $257,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $513M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.